[go: up one dir, main page]

GB1540728A - Polyiodothyronine immunoassay - Google Patents

Polyiodothyronine immunoassay

Info

Publication number
GB1540728A
GB1540728A GB54276A GB54276A GB1540728A GB 1540728 A GB1540728 A GB 1540728A GB 54276 A GB54276 A GB 54276A GB 54276 A GB54276 A GB 54276A GB 1540728 A GB1540728 A GB 1540728A
Authority
GB
United Kingdom
Prior art keywords
polyiodothyronine
enzyme
medium
inhibited
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB54276A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syva Co
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Publication of GB1540728A publication Critical patent/GB1540728A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Physiological amounts of polyiodothyronine in a medium, e.g. serum, are detected or determined by a homogeneous enzyme immunoanalysis. To this end, an enzyme is used which for the most part is reversibly inhibited by polyiodothyronine bound thereto. The medium, the inhibited enzyme and an antibody for polyiodothyronine are brought together in an aqueous zone which contains a substrate for the enzyme. The antibody is employed in an amount such that it substantially increases the enzyme activity of the inhibited enzyme if no free polyiodothyronine is present. If the medium added contains free polyiodothyronine, the increase in the enzyme activity is lower. By determination of the enzyme activity in the aqueous zone, the polyiodothyronine content of the medium can therefore be determined.
GB54276A 1975-02-20 1976-01-07 Polyiodothyronine immunoassay Expired GB1540728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55156675A 1975-02-20 1975-02-20

Publications (1)

Publication Number Publication Date
GB1540728A true GB1540728A (en) 1979-02-14

Family

ID=24201792

Family Applications (1)

Application Number Title Priority Date Filing Date
GB54276A Expired GB1540728A (en) 1975-02-20 1976-01-07 Polyiodothyronine immunoassay

Country Status (7)

Country Link
JP (1) JPS5924386B2 (en)
CA (1) CA1028643A (en)
CH (1) CH632343A5 (en)
DE (2) DE2605162C2 (en)
FR (1) FR2301823A1 (en)
GB (1) GB1540728A (en)
IT (1) IT1052946B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8912010B2 (en) 2011-09-26 2014-12-16 Fujifilm Corporation Thyroxine immunoassay using fluorescent particles

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
IT1153999B (en) * 1977-03-15 1987-01-21 Snam Progetti COMPOSITION SUITABLE FOR DETERMINING TRIIODOTHYRONIN AND DIAGNOSTIC METHOD USING THE SAME
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
GB2102946B (en) * 1981-06-30 1984-11-28 Wellcome Found Enzyme immunoassay
EP0131096A2 (en) * 1983-05-02 1985-01-16 Miles Laboratories, Inc. Homogeneous immunoassay method for determining binding substances and reagent system therefor
CA1317861C (en) * 1987-10-02 1993-05-18 Stephen B. Friedman Homogeneous t-4 uptake assay
FR3146102B1 (en) 2023-02-28 2025-01-10 Psa Automobiles Sa ELECTRIC CHARGING ARRANGEMENT FOR ELECTRIFIED MOTOR VEHICLE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551296A (en) * 1968-06-11 1970-12-29 Calbiochem Reagent and method for assaying malate dehydrogenase
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3852157A (en) * 1971-05-14 1974-12-03 Syva Corp Compounds for enzyme amplification assay
IL39323A (en) * 1971-05-14 1975-08-31 Syva Co Highly sensitive assay method employing an enzyme for amplification

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8912010B2 (en) 2011-09-26 2014-12-16 Fujifilm Corporation Thyroxine immunoassay using fluorescent particles

Also Published As

Publication number Publication date
DE2605162C2 (en) 1986-08-28
CA1028643A (en) 1978-03-28
DE2605162A1 (en) 1976-09-02
DE2660911C2 (en) 1986-05-28
FR2301823A1 (en) 1976-09-17
CH632343A5 (en) 1982-09-30
JPS51106724A (en) 1976-09-21
IT1052946B (en) 1981-08-31
FR2301823B1 (en) 1980-05-23
JPS5924386B2 (en) 1984-06-08

Similar Documents

Publication Publication Date Title
US3654090A (en) Method for the determination of antigens and antibodies
ES398372A1 (en) Process for the detection and determination of specific binding proteins and their corresponding bindable substances
ES414618A1 (en) Improved procedure for the detection and determination of haptens. (Machine-translation by Google Translate, not legally binding)
ATE82072T1 (en) IMMUNOASSAY AND -ROLYMERIC IGG DERIVATIVES FOR COMPENSATION OF INTERFERENCE FACTORS IN IMMUNOASSAYS.
KR830010384A (en) Method for measuring antigen antibody response and its reagent
NO903124D0 (en) TEST METHOD AND REAGENT KIT FOR THIS.
GB2001172A (en) Competitive protein binding assay
ES2022166B3 (en) SPECIFIC HETEROGENEOUS LINK TEST USING AN ADDABLE LINKING REAGENT.
ES467831A1 (en) Enzyme modifier immunoassay
DE3878820D1 (en) DEVICE FOR BINDING TEST.
GB1524372A (en) Radioassay of oestrogens
ES485763A1 (en) Method and composition for direct determination of iron in blood serum
ES2148144T3 (en) PROCEDURE FOR THE STABILIZATION OF ENZYME CONJUGATES.
GB1540728A (en) Polyiodothyronine immunoassay
ES444543A1 (en) Immunological reagent and method of using same
ES402720A1 (en) Enzyme aplification assay
ATE67599T1 (en) HETEROGENOUS IMMUNOASSAY.
DE3473475D1 (en) Process for determining substrate or enzymatic activity
DE3851221D1 (en) NON-DISCONNECTING SOLID PHASE ENZYME TEST.
NO175024C (en) Agglutination reagent and its use for detecting an antigen, antibodies or other analytes, and testing comprising the reagents
ES405388A1 (en) ASSAY PROCEDURE TO DETERMINE THE PRESENCE OF AUSTRALIAN AN-TIGEN FROM A BLOOD SAMPLE.
DE3568639D1 (en) Method for the determination of a substance capable of immunological binding
FR2383962A1 (en) DETERMINATION OF HUMAN BETA-LIPOTROPIN
KR850003169A (en) Measurement method and reagent of basic fetal protein
KR860007545A (en) Method for quantifying human prolyl 4-hydroxylase

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19950107